Mounjaro was first added to the FDAs drug shortage list in 2022, while Zepbound was officially declared in limited supply this April
These medications have demonstrated substantial benefits in glycemic control, weight reduction, and cardiovascular outcomes, contributing to their rapid uptake in clinical practice ( 1 , 3 )
The class of weight loss drugs includes Ozempic and Wegovy
Who Should Choose Tirzepatide: Ideal Candidates: Need maximum weight loss (50+ pounds) Want most effective medication available Can afford $349-$1,069/month depending on option Have BMI 30 (or 27 with comorbidities) Plateaued on semaglutide or other medications No contraindications to GLP-1/GIP agonists Particularly Good For: Significant obesity (BMI 35) Previous weight loss medication failures Those who want best possible results Patients who tolerate GLP-1s well Cost Comparison: Value Analysis: Cost per % Body Weight Lost: Brand-Name Tirzepatide: 22.5% loss at $12,828/year Cost per %: $570 Compounded Tirzepatide (TrimRx): 22.5% loss at $4,188/year Cost per %: $186 Compounded Semaglutide (TrimRx): 14.9% loss at $2,388/year Cost per %: $160 Both compounded options offer excellent value, with semaglutide being slightly more cost-efficient per percentage lost, while tirzepatide produces greater absolute weight loss
Who Benefits from Wolverine Stack Therapy
A recipe that felt perfect at 2.5mg may feel too heavy at 5mg